High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,689,104
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CTMX |
CytomX Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-17 | $124,112 | S | Form 4 |
|
CTMX
S
CytomX Therapeutics, Inc.
BELVIN MARCIA
• Officer • SVP, Chief Scientific Officer
Sell to Cover
2026-03-17
$202,273
|
||||||
| CTMX |
CytomX Therapeutics, Inc.
|
Officer • SVP, Chief Scientific Officer
Sell to Cover
|
2026-03-17 | $202,273 | S | Form 4 |
| CTMX |
CytomX Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-17 | $764,138 | S | Form 4 |
|
CTMX
S
CytomX Therapeutics, Inc.
Chu Yu-Waye
• Officer • Chief Medical Officer
Sell to CoverΔOwn -10.1%
2026-03-17
$136,675
|
||||||
| CTMX |
CytomX Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to CoverΔOwn -10.1%
|
2026-03-17 | $136,675 | S | Form 4 |
| CTMX |
CytomX Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-06 | $461,906 | S | Form 4 |